Baseline surveillance in Li-Fraumeni syndrome using whole-body magnetic resonance imaging: a meta-analysis ML Ballinger, A Best, PL Mai, PP Khincha, JT Loud, JA Peters, MI Achatz, ... JAMA oncology 3 (12), 1634-1639, 2017 | 171 | 2017 |
Clinical application of multigene panels: challenges of next-generation counseling and cancer risk management TP Slavin, M Niell-Swiller, I Solomon, B Nehoray, C Rybak, KR Blazer, ... Frontiers in oncology 5, 208, 2015 | 120 | 2015 |
Somatic TP53 variants frequently confound germ-line testing results JN Weitzel, EC Chao, B Nehoray, LR Van Tongeren, H LaDuca, ... Genetics in medicine 20 (8), 809-816, 2018 | 112 | 2018 |
Prospective study of cancer genetic variants: variation in rate of reclassification by ancestry TP Slavin, LR Van Tongeren, CE Behrendt, I Solomon, C Rybak, ... JNCI: Journal of the National Cancer Institute 110 (10), 1059-1066, 2018 | 62 | 2018 |
Pathogenic and likely pathogenic variants in PALB2, CHEK2, and other known breast cancer susceptibility genes among 1054 BRCA‐negative Hispanics with … JN Weitzel, SL Neuhausen, A Adamson, S Tao, C Ricker, A Maoz, ... Cancer 125 (16), 2829-2836, 2019 | 55 | 2019 |
Genetic gastric cancer susceptibility in the international clinical cancer genomics community research network T Slavin, SL Neuhausen, C Rybak, I Solomon, B Nehoray, K Blazer, ... Cancer genetics 216, 111-119, 2017 | 52 | 2017 |
Next-generation testing for cancer risk: perceptions, experiences, and needs among early adopters in community healthcare settings KR Blazer, B Nehoray, I Solomon, M Niell-Swiller, JO Culver, GC Uman, ... Genetic testing and molecular biomarkers 19 (12), 657-665, 2015 | 51 | 2015 |
Loss-of-function variants in CTNNA1 detected on multigene panel testing in individuals with gastric or breast cancer DF Clark, ST Michalski, R Tondon, B Nehoray, J Ebrahimzadeh, ... Genetics in Medicine 22 (5), 840-846, 2020 | 45 | 2020 |
The spectrum of genetic variants in hereditary pancreatic cancer includes Fanconi anemia genes TP Slavin, SL Neuhausen, B Nehoray, M Niell-Swiller, I Solomon, ... Familial cancer 17, 235-245, 2018 | 29 | 2018 |
Mendelian randomisation study of height and body mass index as modifiers of ovarian cancer risk in 22,588 BRCA1 and BRCA2 mutation carriers F Qian, MA Rookus, G Leslie, HA Risch, MH Greene, CM Aalfs, MA Adank, ... British journal of cancer 121 (2), 180-192, 2019 | 26 | 2019 |
Genetic epidemiology of BRCA1- and BRCA2-associated cancer across Latin America JS Herzog, Y Chavarri-Guerra, D Castillo, J Abugattas, C Villarreal-Garza, ... NPJ breast cancer 7 (1), 107, 2021 | 22 | 2021 |
The burden of breast cancer predisposition variants across the age spectrum among 10 000 patients Y Chavarri‐Guerra, CB Hendricks, S Brown, C Marcum, M Hander, ... Journal of the American Geriatrics Society 67 (5), 884-888, 2019 | 14 | 2019 |
Clinical application of multigene panels: challenges of next-generation counseling and Cancer risk management. Front Oncol. 2015; 5: 208 TP Slavin, M Niell-Swiller, I Solomon, B Nehoray, C Rybak, KR Blazer, ... | 14 | 2015 |
Corrigendum: Clinical application of multigene panels: challenges of next-generation counseling and cancer risk management TP Slavin, M Niell-Swiller, I Solomon, B Nehoray, C Rybak, KR Blazer, ... Frontiers in Oncology 5, 271, 2015 | 13 | 2015 |
First estimates of diffuse gastric cancer risks for carriers of CTNNA1 germline pathogenic variants M Coudert, Y Drouet, H Delhomelle, M Svrcek, PR Benusiglio, F Coulet, ... Journal of medical genetics 59 (12), 1189-1195, 2022 | 11 | 2022 |
Development and pilot implementation of the Genomic Risk Assessment for Cancer Implementation and Sustainment (GRACIAS) intervention in Mexico KR Blazer, Y Chavarri-Guerra, C Villarreal Garza, B Nehoray, A Mohar, ... JCO Global Oncology 7, 992-1002, 2021 | 10 | 2021 |
Clonal Hematopoiesis and Mosaicism Revealed by a Multi-Tissue Analysis of Constitutional TP53 Status D Castillo, TA Yuan, B Nehoray, A Cervantes, KK Tsang, K Yang, ... Cancer Epidemiology, Biomarkers & Prevention 31 (8), 1621-1629, 2022 | 6 | 2022 |
Multigene assessment of genetic risk for women for two or more breast cancers JN Weitzel, J Kidd, R Bernhisel, S Shehayeb, P Frankel, KR Blazer, ... Breast cancer research and treatment 188, 759-768, 2021 | 5 | 2021 |
Experience gained from the development and execution of a multidisciplinary multi-syndrome hereditary colon cancer family conference I Solomon, C Rybak, L Van Tongeren, L Kuzmich, K Blazer, B Nehoray, ... Journal of Cancer Education 34, 1204-1212, 2019 | 4 | 2019 |
Assessment of the clinical presentation of patients with at least two deleterious mutations on multi-gene panel testing. JN Weitzel, KR Blazer, B Nehoray, J Kidd, TP Slavin, I Solomon, ... Journal of Clinical Oncology 33 (15_suppl), 1514-1514, 2015 | 4 | 2015 |